Search

We improved the power conversion efficiency (PCE) of the small molecular (S-M) tandem organic solar cells (TOSCs) by employing different low work function alloy nanoparticle intermediate layers. The enhancement of the PCE was mainly attributed to the gap states formed at the interface between the buffer layer and alloy nanoparticle intermediate layer. The gap states result in the disappearance of the electron injection barrier. Compared with the planar heterojunction (PHJ) TOSCs with single Ag nanoparticle intermediate layer, the PCE of the PHJ TOSC with the Mg-Ag alloy nanoparticle intermediate layer exhibits an enhancement of 7.5%. Moreover, the Mg-Ag alloy nanoparticle intermediate layer was also employed in the bulk-heterojunction (BHJ) TOSCs. Compared with the PHJ TOSCs, the PCE of the BHJ TOSCs with Mg-Ag alloy nanoparticle intermediate layer is doubled and achieves a value of 5.54%.

A broadband-absorption enhancement in two kinds of polymer-based organic solar cells (OSCs) is demonstrated in this work by employing micro-nano composite gratings (MNCGs). The structure of MNCGs is nano-grating covering on the surface of micro-grating. By embedding the MNCGs at the interface of the active layer/Ag cathode, the multi-absorption-enhancement mechanisms, such as dual-microcavity resonance, plasmon-cavity polaritons and light-scattering effects, are excited and result in a broadband-absorption enhancement. The light absorption of active layer in the MNCG-based OSC is numerically calculated. As a result, comparing to the planar OSCs, the absorption intensity is increased by 50.41% and 20.43% in these two kinds of polymer-based OSCs, respectively. Meanwhile, the MNCGs can also be universally used in all kinds of polymer-based OSCs to increase the light absorption of the active layer.

The efficient cross coupling between the surface plasmon–polariton (SPP) and microcavity modes was employed in the top-emitting organic light-emitting devices (TOLEDs) to release the trade-off between efficiency and stability by using a periodic corrugated Ag cathode. As the main factors affecting the cross coupling, the thickness and period of the corrugated Ag cathode were optimized to excite the SPP at the two interfaces of the Ag cathode and achieve a matched resonance wavelength between the SPP and the microcavity mode. At the optimal values of the thickness and period, the cross coupling between the SPP and microcavity modes enhanced the light extraction efficiency, and the efficiency of the corrugated TOLEDs was enhanced by 38.6% at the current density of 100 mA cm−2.

Objective Activation of hedgehog (Hh) pathway has been implicated in the development of human malignancies. Hh as well as related downstream target genes has been extensively studied in many kinds of malignant tumours for clinical diagnostic or prognostic utilities. This study aimed at investigating whether Hh molecules provides a molecular marker of hepatoblastoma malignancy. Methods We obtained tissue sections from 32 patients with hepatoblastoma as well as cholestasis and normal control. Immunohistochemical analysis were performed to determine Hh signal components in human hepatoblastoma. The prognostic significance of single expression of Hh signal components were evaluated using Cox proportional hazards regression models and Kaplan-Meier survival analysis for statistical analysis. Results Expression of Hh signal components showed an increase in hepatoblastoma compared with chole stasis and normal tissues. There was a positive correlation between Smo or Gli1 expression and tumor clinicopathological features, such as histological type, tumor grade, tumor size and clinical stage. Both Smo or Gli1 protein high expression was significantly associated with poor prognosis by univariate analyses and multivariate analyses. Conclusions Abnormal Hh signaling activation plays important roles in the malignant potential of hepatoblastoma. Gli1 expression is an independent prognostic marker.

The cellular origin of myofibroblast in the liver fibrosis remains unclear. This study was designed to investigate whether biliary epithelial cells (BECs) undergoing epithelial–mesenchymal transition (EMT) might be found in patients with biliary atresia, thereby serving as a source of fibrotic myofibroblasts. Liver sections from patients with biliary atresia were evaluated to detect antigen for the BECs marker 4 and cytokeratin-7 (CK-7), proteins (fibroblast-specific protein 1, also known S100A4; the collagen chaperone heat shock protein 47, HSP47) characteristically expressed by cells undergoing EMT, as well as myofibroblasts marker a-smooth muscle actin (a-SMA). Normal bile ducts BECs could express CK-7 and low levels of a-SMA; they did not express S100A4 and HSP47. However, BECs from biliary atresia resulted in increased expression of a-SMA, S100A4, with concurrent transition to a fibroblast-like morphology and decreased expression of AK-7. Furthermore, BECs in biliary atresia were associated with significant bile ductular proliferation and coexpressed both epithelial and mesenchymal markers. From significant histologic evidence, the BECs forming small- and medium-sized bile ducts undergoing EMT may account for prominent bile ductular proliferation and directly contribute to fibrogenesis in BA.

AIM: To develop orthotopic gastric cancer mouse models from different cell lines and characterize the tumor features to assist further in preclinical trials and clinical treatment strategies. METHODS: Human gastric cancer SGC-7901 and BGC-823 cell suspensions were injected subcutaneously into nude mice to develop solid tumors, and tumor tissue pieces were then implanted under the serous coat of the stomach. An autopsy was performed on all animals of the SGC-7901 and BGC-823 models to observe the primary tumor growth and metastases using pathological and immunohistochemical methods. RESULTS: Both models showed large tumors in situ resulting in pressure and infiltration of the adjacent organs. The gastric cavity became smaller, along with stenosis of the cardia or pylorus. There were biological and statistical differences between the two models. The metastasis rate in involved organs (lymph nodes, kidney, spleen, testis) was significantly higher in the BGC-823 model compared to the SGC-7901 model (P < 0.05 or P < 0.01). The median survival of the BGC-823 model was shorter than that of SGC-7901 (23 d vs 84 d, P < 0.05). Histopathologically, the primary tumor and metastatic lesions of the two models showed obvious atypia and mucus in the cytoplasm. Compared with the SGC-7901 model, BGC-823 appeared more poorly differentiated (absence of adenoid structure), had a smaller volume, and richer capillary structure. Immunohistochemical staining revealed cytokeratin 20 and epithelial membrane antigen expression was positive in the SGC-7901 tumors, while negative in BGC-823 ones. CONCLUSION: Models using the SGC-7901 and BGC-823 cell lines were established which could function in gastric cancer research on carcinogenesis mechanism and drug discovery. The two models showed different tumor behavior and the latter was more malignant than the former.

AIM: To establish a gastric cancer nude-mouse model with improved orthotopic implantation and investigate its biological characteristics at different time points. METHODS: Human gastric cancer SGC-7901 cell suspensions were injected subcutaneously into a nude mouse to develop solid tumors, and the tumor tissue pieces were implanted under the serous coat. The nude mice were then euthanized in group every two weeks to observe the primary tumor growth and metastases. RESULTS: Within 2-4 wk, there were no obvious changes about the primary tumor in stomach. At the sixth week, the primary tumor began to grow fast, resulting in incrassation of the gastric wall and stenosis of the gastric cavity, and metastases into the liver and lymph nodes were detected. The tumor, which compressed the adjacent organs, gradually became bigger and bigger followed by stenosis or vanishment of the gastric cavity from 8 to 12 wk. There were massive metastases, and the rate of metastasis was 58% in lymph nodes, 78% in liver, 39% in kidney, and 81% in peritoneum or septum. CONCLUSION: A gastric cancer model is established, which can simulate the clinical tumor behavior and provide experimental carrier for clinical trials of gastric cancer treatment.